SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
14707831
Source:
http://linkedlifedata.com/resource/pubmed/id/14707831
Search
Subject
(
60
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008976
,
umls-concept:C0035820
,
umls-concept:C0087111
,
umls-concept:C0175668
,
umls-concept:C0209211
,
umls-concept:C0242383
,
umls-concept:C0473169
,
umls-concept:C0600518
pubmed:issue
6
pubmed:dateCreated
2004-1-6
pubmed:abstractText
To evaluate the role of somatostatin in the treatment of subfoveal choroidal neovascularization (CNV).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309919
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents...
,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides, Cyclic
,
http://linkedlifedata.com/resource/pubmed/chemical/Somatostatin
,
http://linkedlifedata.com/resource/pubmed/chemical/lanreotide
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0275-004X
pubmed:author
pubmed-author:KaravellasMarietaM
,
pubmed-author:KouromalisEliasE
,
pubmed-author:LinardakisManolisM
,
pubmed-author:PallikarisIoannisI
,
pubmed-author:PapadakiTheklaT
,
pubmed-author:PapapdakisAntonisA
,
pubmed-author:SamonakisDimitrosD
,
pubmed-author:ThermosKyriakiK
,
pubmed-author:TsilimbarisMiltiadisM
pubmed:issnType
Print
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
800-7
pubmed:dateRevised
2006-12-15
pubmed:meshHeading
pubmed-meshheading:14707831-Aged
,
pubmed-meshheading:14707831-Anti-Inflammatory Agents, Non-Steroidal
,
pubmed-meshheading:14707831-Choroidal Neovascularization
,
pubmed-meshheading:14707831-Drug Evaluation
,
pubmed-meshheading:14707831-Female
,
pubmed-meshheading:14707831-Fluorescein Angiography
,
pubmed-meshheading:14707831-Follow-Up Studies
,
pubmed-meshheading:14707831-Humans
,
pubmed-meshheading:14707831-Injections, Intramuscular
,
pubmed-meshheading:14707831-Macular Degeneration
,
pubmed-meshheading:14707831-Male
,
pubmed-meshheading:14707831-Peptides, Cyclic
,
pubmed-meshheading:14707831-Pilot Projects
,
pubmed-meshheading:14707831-Prospective Studies
,
pubmed-meshheading:14707831-Somatostatin
,
pubmed-meshheading:14707831-Treatment Outcome
,
pubmed-meshheading:14707831-Visual Acuity
pubmed:year
2003
pubmed:articleTitle
The role of lanreotide in the treatment of choroidal neovascularization secondary to age-related macular degeneration: a pilot clinical trial.
pubmed:affiliation
Department of Ophthalmology, University of Crete Medical School, Heraklion, Crete, Greece.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial